Optimized treatment for H. pylori infection with stronger acid control
Treatments studied
This study tests a new combination of medicines to treat H. pylori, a common stomach infection that can cause ulcers. The goal is to see if a stronger acid-reducing approach helps the treatment work better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have a confirmed H. pylori infection (tested positive).
- You have never been treated for H. pylori before.
- You are not allergic to any of the study drugs (keverprazan, amoxicillin, minocycline, bismuth).
- You do not have severe health conditions like liver or kidney failure, cancer, or serious heart/lung disease.
- You have not taken certain antibiotics, acid reducers, or herbal medicines recently (within 2-4 weeks).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a new type of acid-reducing drug (vonoprazan) works better than a common one (proton pump inhibitor) when combined with vitamin D or probiotics to clear H. pylori, a bacteria that can cause stomach problems. If you have H. pylori and haven't been treated for it before, this study may be for you.
This trial tests a 14-day treatment using two medicines, vonoprazan and minocycline, to get rid of an H. pylori infection in the stomach. It aims to see if this combination is safe and works well, and might be a simpler option for people who haven't been treated for H. pylori before.
This study compares two different acid-reducing medications, given with or without zinc, to see which is safer and works best for treating H. pylori. All treatments are combined with two antibiotics.
This trial tests a new medication called Keverprazan to see if it can safely and effectively clear an H. pylori infection in the stomach. It is for people who have not yet been treated for this infection.
This trial tests a two-drug combination (keverprazan and amoxicillin) to see if it works better for treating H. pylori, a bacteria that can cause stomach problems. It is for people who have had H. pylori before and need treatment again.
This trial tests a two-drug treatment (keverprazan and amoxicillin) for people who have H. pylori and have not been treated for it before. The goal is to see if this newer combination works well and is safe.
Hear when a new HELICOBACTER PYLORI INFECTIONS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.